Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.97 Analyst target: $25.45 Upside: 265.14%
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company is headquartered in Bedford, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.